« Back
Home /
CMV EP 88, Cytomegalovirus Early Protein pp89 Derivative

CMV EP 88, Cytomegalovirus Early Protein pp89 Derivative

Item no.	RP20272
Manufacturer	GenScript
Amount	1 mg
Category	Oncology By Cell Type Hematology Leukemia Peptides & Proteins Peptides
Type	Peptides
Specific against	other
Sequence	YPHFMPTNL ; {Tyr}{Pro}{His}{Phe}{Met}{Pro}{Thr}{Asn}{Leu}
ECLASS 10.1	32160409
ECLASS 11.0	32160409
UNSPSC	12352202
Alias	peptide/RP20272-CMV_EP_88, This peptide is processed from the immediate early protein pp89 of mouse cytomegalovirus (CMV). It is presented to CD8+ T lymphocytes by the H-2 Ld molecule. Infection of mice with murine CMV leads to CD8 cell responses to this immunodominant epitope. This peptide was employed in vaccines development. </td></tr>
Similar products	CMV
Available
Country of Origin	USA
Description	This peptide is processed from the immediate early protein pp89 of mouse cytomegalovirus (CMV). It is presented to CD8+ T lymphocytes by the H-2 Ld molecule. Infection of mice with murine CMV leads to CD8 cell responses to this immunodominant epitope. This peptide was employed in vaccines development.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 1 mg

available

Delivery expected until 1/8/2026

Express Delivery: Save 3 days

Compare

Add to wishlist

Get an offer